By vgreene, 10 July, 2019 If squamous cell carcinoma AND advanced/metastatic dz, then consider, at minimum:
By vgreene, 10 July, 2019 KRAS1,2 prognostic; not indicated as routine stand-alone assay as a sole determinant of targeted tx; appropriate to include KRAS as part of larger testing panels performed either initially or when routine EFGR, ALK, BRAF, and ROS1 testing is negative2